NCT03034720

Brief Summary

SPECIFIC AIMS While post-concussive symptoms following sports-related concussion are typically transient and resolve spontaneously within two weeks of concussive injury, 14% or more of youth who sustain concussion experience significant morbidity that can persist well beyond the normal disease course.Furthermore, post-concussive symptoms commonly co-occur with affective symptoms including depression and anxiety which when present can prolong recovery from primary post-concussive symptoms. Together, persistent physical and psychological symptoms confer protracted functional impairment and create a significant burden for affected youth, their family, and school. Currently, there are no evidence-based guidelines to inform treatment of persistent post-concussive symptoms in youth and adolescents. In response to the dearth of evidence-based treatment approaches for youth with persistent post-concussive symptoms, the investigators developed a novel collaborative care treatment model that simultaneously targets post-concussive symptoms and co-occurring depression and anxiety. Athletes and their family members receive patient navigator care management services that bridge post-injury care across acute care, specialist and primary care health service delivery sectors, in addition to cognitive behavioral psychotherapy. Patients who remain symptomatic after initial treatment efforts receive stepped-up care that may include psychopharmacologic consultation. The Investigators have demonstrated feasibility of the intervention model through a pilot randomized-control trial of 49 adolescents with persistent post-concussive symptoms recruited from a regional children's hospital. Participants assigned to the intervention condition demonstrated significant and clinically-meaningful reductions in post-concussive and depressive symptoms as well as health-related quality of life as compared to adolescents in the usual care arm of the trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 27, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

March 9, 2017

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2020

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

3.2 years

First QC Date

January 11, 2017

Last Update Submit

April 5, 2021

Conditions

Keywords

Concussionpersistent post-concussive symptomsCBTcollaborative careDepressionAnxiety

Outcome Measures

Primary Outcomes (5)

  • Post-concussive symptoms measured with the HBI

    The central hypothesis is that the two groups will have different patterns of HBI scores over time, with the intervention group showing significant. reductions when compared to controls.

    During the12 months after enrollment.

  • Health related quality of life as measured with the PedsQL

    The hypothesis is that the two groups will have different patterns of PEDSQL scores over time, with the intervention group showing significant reductions when compared to controls.

    During the 12 months after enrollment

  • Depressive symptoms measured by the PHQ-9

    The hypothesis is that the two groups will have different patterns of PHQ-9 scores over time, with the intervention group showing significant. reductions when compared to controls.

    During the12 months after enrollment.

  • Anxiety symptoms measured by the GAD-7

    The hypothesis is that the two groups will have different patterns of GAD-7 scores over time, with the intervention group showing significant reductions when compared to controls.

    During the 12 months after enrollment

  • Anxiety symptoms measured by the RCADS

    The hypothesis is that the two groups will have different patterns of RCADS scores over time, with the intervention group showing significant reductions when compared to controls.

    During the 12 months after enrollment

Secondary Outcomes (2)

  • School performance as measured by GPA

    During the 12 months after enrollment

  • Return to full activities at school as measured by the CLASS

    During the 12 months after enrollment

Other Outcomes (1)

  • Exploratory Outcome Measure

    During the 12 months after enrollment

Study Arms (2)

Intervention

EXPERIMENTAL

Intervention subjects will receive treatment from an MSW-trained care manager over the course of 6-months after randomization. Intervention team members will work collaboratively with primary care providers to link physical and mental health care longitudinally through outpatient follow-up and community rehabilitation. Intervention subjects and their families and collaborative team members will share information and deliberate treatment decisions with each other in order to develop an individually tailored treatment plan. Stepped, higher intensity care will be available for intervention subjects with recurrent symptoms. Stepped up care will include CBT booster sessions targeting post-concussive and related symptom comorbidity as well as psychopharmacologic assessment and treatment.

Behavioral: Collaborative Care

Control

NO INTERVENTION

Adolescent subjects in the control group will receive care as usual from their health care providers, a standard that is ethically acceptable.

Interventions

Intervention subjects will receive treatment from an MSW-trained care manager over the course of 6-months after randomization. Intervention team members will work collaboratively with primary care providers to link physical and mental health care longitudinally through outpatient follow-up and community rehabilitation. Intervention subjects and their families and collaborative team members will share information and deliberate treatment decisions with each other in order to develop an individually tailored treatment plan. Stepped, higher intensity care will be available for intervention subjects with recurrent symptoms. Stepped up care will include CBT booster sessions targeting post-concussive and related symptom comorbidity as well as psychopharmacologic assessment and treatment.

Intervention

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English speaking male and female sports-injured adolescents
  • ages 11-18
  • health care provider diagnosed concussion and with ≥ 3 HBI symptoms that have endured or worsened for at least 1-month but less than 9 months since injury will be included in the investigation.

You may not qualify if:

  • Adolescents who require immediate intervention (e.g., acute suicidal ideation) will be excluded.
  • Adolescents whose parents report that their child has ever had a diagnosis of schizophrenia or psychosis will be excluded from the study.
  • Adolescents whose parents report concerns about their child's ability to communicate may be excluded from the study (pending consult with PIs).
  • Adolescents who have suffered spinal cord or other severe injuries that prevent participation will be excluded from the study.
  • Adults unable to consent are not included in this research
  • Adolescents and parents who do not read and speak English will not be included
  • Wards of the state are not included in this research
  • Pregnant women are not included in this research
  • Prisoners are not included in this research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seattle Childrens Hospital

Seattle, Washington, 98105, United States

Location

Related Publications (6)

  • Payne KM, Prentice ET, Marcynyszyn LA, McCarty CA. Goals for Persistent Postconcussive Symptom Treatment From Adolescent and Parent Perspectives. JAMA Pediatr. 2020 Dec 1;174(12):1210-1211. doi: 10.1001/jamapediatrics.2020.0898.

    PMID: 32391873BACKGROUND
  • Marcynyszyn LA, McCarty CA, Rivara FP, Johnson AM, Wang J, Zatzick DF. Parent Traumatic Events and Adolescent Internalizing Symptoms: The Mediating Role of Parental Depression Among Youth with Persistent Post-concussive Symptoms. J Pediatr Psychol. 2021 Jun 3;46(5):547-556. doi: 10.1093/jpepsy/jsaa128.

    PMID: 33411915BACKGROUND
  • McCarty CA, Zatzick D, Hoopes T, Payne K, Parrish R, Rivara FP. Collaborative care model for treatment of persistent symptoms after concussion among youth (CARE4PCS-II): Study protocol for a randomized, controlled trial. Trials. 2019 Sep 18;20(1):567. doi: 10.1186/s13063-019-3662-3.

    PMID: 31533799BACKGROUND
  • Johnson AM, McCarty CA, Marcynyszyn LA, Zatzick DF, Chrisman SP, Rivara FP. Child- compared with parent-report ratings on psychosocial measures following a mild traumatic brain injury among youth with persistent post-concussion symptoms. Brain Inj. 2021 Apr 16;35(5):574-586. doi: 10.1080/02699052.2021.1889663. Epub 2021 Mar 18.

    PMID: 33733955BACKGROUND
  • McCarty CA, Zatzick DF, Marcynyszyn LA, Wang J, Hilt R, Jinguji T, Quitiquit C, Chrisman SPD, Rivara FP. Effect of Collaborative Care on Persistent Postconcussive Symptoms in Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2021 Feb 1;4(2):e210207. doi: 10.1001/jamanetworkopen.2021.0207.

  • Marcynyszyn LA, McCarty CA, Chrisman SPD, Zatzick DF, Johnson AM, Wang J, Hilt RJ, Rivara FP. Psychometric Properties and Validation of the General Anxiety Disorder 7-Item Scale Among Adolescents With Persistent Post-Concussive Symptoms. Neurotrauma Rep. 2023 Apr 27;4(1):276-283. doi: 10.1089/neur.2022.0075. eCollection 2023.

MeSH Terms

Conditions

Brain ConcussionDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingBehavioral SymptomsBehaviorMental Disorders

Study Officials

  • Frederick P Rivara, MD

    Seattle Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

January 11, 2017

First Posted

January 27, 2017

Study Start

March 9, 2017

Primary Completion

May 29, 2020

Study Completion

May 29, 2020

Last Updated

April 8, 2021

Record last verified: 2021-04

Locations